151 related articles for article (PubMed ID: 36329448)
1. HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma.
Zhang L; Shi B; Hu M; Qian L
World J Surg Oncol; 2022 Nov; 20(1):353. PubMed ID: 36329448
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress.
Song H; Chen X; Jiao Q; Qiu Z; Shen C; Zhang G; Sun Z; Zhang H; Luo QY
Thyroid; 2021 Feb; 31(2):233-246. PubMed ID: 32772829
[No Abstract] [Full Text] [Related]
3. In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF (V600E) mutation status and together with hypoxia-related proteins predicts aggressive behavior.
Ilie MI; Lassalle S; Long-Mira E; Hofman V; Zangari J; Bénaim G; Bozec A; Guevara N; Haudebourg J; Birtwisle-Peyrottes I; Santini J; Brest P; Hofman P
Virchows Arch; 2013 Sep; 463(3):437-44. PubMed ID: 23893334
[TBL] [Abstract][Full Text] [Related]
4. Expression of HIF-1α/PKM2 axis correlates to biological and clinical significance in papillary thyroid carcinoma.
Hao Z; Wang Y; Li J; Liu W; Zhao W; Wang J
Medicine (Baltimore); 2023 Mar; 102(10):e33232. PubMed ID: 36897686
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of HIF-1α, metallothionein and SLUG is associated with high TNM stage and lymph node metastasis in papillary thyroid carcinoma.
Wang N; Dong CR; Jiang R; Tang C; Yang L; Jiang QF; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2014; 7(1):322-30. PubMed ID: 24427353
[TBL] [Abstract][Full Text] [Related]
6. The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis.
Lin X; Su H; Huo J; Zhang F
Medicine (Baltimore); 2023 Jun; 102(24):e34045. PubMed ID: 37327294
[TBL] [Abstract][Full Text] [Related]
7. Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma.
Liu YM; Ying SP; Huang YR; Pan Y; Chen WJ; Ni LQ; Xu JY; Shen QY; Liang Y
World J Surg Oncol; 2016 Feb; 14(1):30. PubMed ID: 26846782
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression.
Song H; Qiu Z; Wang Y; Xi C; Zhang G; Sun Z; Luo Q; Shen C
Int J Biol Sci; 2023; 19(1):225-241. PubMed ID: 36594102
[No Abstract] [Full Text] [Related]
9. Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis.
Koperek O; Akin E; Asari R; Niederle B; Neuhold N
Virchows Arch; 2013 Dec; 463(6):795-802. PubMed ID: 24197448
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway.
Wang D; Liu X; Li M; Ning J
Mol Carcinog; 2024 Feb; 63(2):238-252. PubMed ID: 37861358
[TBL] [Abstract][Full Text] [Related]
11. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
12. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
Kim MH; Ko SH; Bae JS; Lee SH; Jung CK; Lim DJ; Baek KH; Kim SH; Lee JM; Kang MI; Cha BY
Thyroid; 2013 Nov; 23(11):1452-60. PubMed ID: 23688271
[TBL] [Abstract][Full Text] [Related]
13. Expression of caspase-3 and hypoxia inducible factor 1α in hepatocellular carcinoma complicated by hemorrhage and necrosis.
Liang H; Wu JG; Wang F; Chen BX; Zou ST; Wang C; Luo SW
World J Clin Cases; 2021 Aug; 9(23):6725-6733. PubMed ID: 34447819
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of hypoxia-inducible factor-1alpha expression in human pancreatic carcinoma.
Kitada T; Seki S; Sakaguchi H; Sawada T; Hirakawa K; Wakasa K
Histopathology; 2003 Dec; 43(6):550-5. PubMed ID: 14636255
[TBL] [Abstract][Full Text] [Related]
15. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways.
Burrows N; Babur M; Resch J; Ridsdale S; Mejin M; Rowling EJ; Brabant G; Williams KJ
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1934-43. PubMed ID: 21994956
[TBL] [Abstract][Full Text] [Related]
16. [Effects of hypoxia-inducible factor 1α on hypoxic tolerance of human amniotic mesenchymal stem cells].
Ge L; Yu D; Su R; Cao Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 Mar; 32(3):264-269. PubMed ID: 29806273
[TBL] [Abstract][Full Text] [Related]
17. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
18. [Effect of HIF-1α and BRD4 on autophagy level of breast cancer cell in hypoxic microenvironment].
Lian YE; Wu D; Huang JP; Zheng QL; Bai YN; Feng CY; Yang YH
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1294-1299. PubMed ID: 33287516
[No Abstract] [Full Text] [Related]
19. Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma.
Batmunkh E; Shimada M; Morine Y; Imura S; Kanemura H; Arakawa Y; Hanaoka J; Kanamoto M; Sugimoto K; Nishi M
Int J Clin Oncol; 2010 Feb; 15(1):59-64. PubMed ID: 20082206
[TBL] [Abstract][Full Text] [Related]
20. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
